LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • BioMarin Pharmaceutical To Acquire Amicus Therapeutics For Approx. $4.8 Bln 12/19/2025 7:47:37 AM
  • FDA Accepts BioMarin’s SBLA For PALYNZIQ In Adolescents With PKU; Priority Review Target Set For Feb. 28, 2026 10/29/2025 9:02:29 AM
  • Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) FY 25 Rev. Estimate To 3198 M From 3175 M 10/28/2025 11:43:31 AM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q4 25 Rev. Estimate To 851.7 M From 829.6 M 10/28/2025 11:43:10 AM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY 25 Estimate To 2.96 From 4.17 10/28/2025 11:42:37 AM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q4 25 Estimate To 0.94 From 1.07 10/28/2025 11:42:27 AM
  • Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $94 Price Target 10/28/2025 11:41:59 AM
  • BioMarin Q3 Loss/share $0.16 Vs. Profit $0.55 Year Ago 10/27/2025 4:04:47 PM
  • Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) FY25 Rev. Estimate To 3175 M From 3094 M 8/5/2025 10:20:10 AM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q4 25 Rev. Estimate To 829.6 M From 819.6 M 8/5/2025 10:20:00 AM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q3 25 Rev. Estimate To 775.3 M From 766.3 M 8/5/2025 10:19:49 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap